Extravascular transport of anticancer agents
Professor Bill Wilson and Dr Kevin Hicks
Auckland Cancer Society Research Centre
ACSRC Research groups
Our research warriors at the ACSRC are fighting to conquer cancer, one of the biggest killers in New Zealand.
Read more about our cutting edge cancer research groups:
You may also be interested in Dr Hicks' research with Pre-clinical models
Experimental Therapeutics Group
Exploiting the tumour microenvironment to improve cancer targeting and therapy.
SN 30000 and related tirapazamine analogues as hypoxia-selective anticancer drugs
Professor Bill Wilson, Dr Kevin Hicks and Dr Jingli Wang
Hypoxia-selective prodrugs of minor groove alkylators
Dr Frederik Pruijn
PR104 and related dinitrobenzamide mustard prodrugs
Professor Bill Wilson and Dr Adam Patterson
Read more about the Experimental Therapeutics Group
Medicinal Chemistry Group
Design, synthesis and development of new drugs for the treatment of cancer, tuberculosis and immunosuppression.
Development of novel tuberculosis drugs
Associate Professor Brian Palmer
Free Radical Research (FRR) Group
Associate Professor Bob Anderson
Molecular Modelling
Dr Jack Flannagan
Perforin Inhibitors
Dr Julie Spicer
Targeting neglected tropical diseases
Dr Andrew Thompson
Selective DNA alkylating agents
Dr Moana Tercel
Selective Inhibitors of Phoso-inositide 3-Kinases
Professor Bill Denny, Associate Professor Gordon Rewcastle and Dr Jackie Kendall
Targeting hypoxia and HIF-1
Associate Professor Mike Hay
Next generation bioreductive prodrugs
Dr Jeff Smaill
Read more about the Medicinal Chemistry Group
Stromal Targeting Group
Project Leader: Professor Lai-Ming Ching
Targeting the tumor stroma to kill the cancer
Read more about the Stromal Targeting Group
Translational Therapeutics Team
Project Leader: Dr Adam Patterson
The discovery and development of novel anticancer therapies including small molecules and biological agents.
Read more about the Translational Therapeutics Team
Tumour Biology Group
Project Leader: Professor Bruce Baguley
The development of topoisomerase inhibitors and determination of their mechanism of action, analysing the effect drugs have on the cell cycle, and the investigation of resistance mechanisms.
Read more about the Tumour Biology Group
